Inventor
Guoqing Li
Inventor
Belle Mead, NJ, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes20%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for3%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation3%
C04BLime, magnesia3%
C12NMicroorganisms or enzymes3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
C12YEnzymes3%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
10,688,082Aminopyrazine compounds with A2A antagonist properties202010,428,364Enzymatic method for preparing rebaudioside M201910,428,076Soluble guanylate cyclase stimulators201910,301,662Enzymatic method for preparing rebaudioside M201910,030,027Soluble guanylate cyclase stimulators20189,839,642'Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors'20179,708,336'Metallo-beta-lactamase inhibitors'20179,586,948'Inhibitors of IRAK4 activity'20179,475,785'Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use'20169,382,242'Preparation and use of compounds as protease inhibitors'20169,169,260'Amidopyrazole inhibitors of interleukin receptor-associated kinases'20158,829,036'Heterocyclic aspartyl protease inhibitors'20148,722,708'Substituted isoindolines as aspartyl protease inhibitors'20148,691,831'Heterocyclic aspartyl protease inhibitors'20148,691,833'Heterocyclic aspartyl protease inhibitors'20148,541,427'Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use'20138,367,712'Substituted amide beta secretase inhibitors'20138,183,252'Heterocyclic aspartyl protease inhibitors'20128,012,953'Macrocyclic beta-secretase inhibitors'20117,910,590'Cyclic amine bace-1 inhibitors having a heterocyclic substituent'20117,803,802'Substituted amide beta secretase inhibitors'20107,763,609'Heterocyclic aspartyl protease inhibitors'20107,652,003'Macrocyclic β-secretase inhibitors'20107,598,250'Cyclic amine BACE-1 inhibitors having a heterocyclic substituent'20096,667,319'Neuropeptide Y Y5 receptor antagonists'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003Based in Staten Island, NY, US· patent location history
2009–2012Patents assigned to SCHERING CORP (6)· patent assignee history
2009–2020Based in Belle Mead, NJ, US· patent location history
2012–2015Patents assigned to LI GUOQING (8)· patent assignee history
2012–2014Patents assigned to HUANG YING (6)· patent assignee history
2012–2014Patents assigned to ZHU ZHAONING (6)· patent assignee history
2013–2020Patents assigned to MERCK SHARP & DOHME (14)· patent assignee history
2013Based in Kenilworth, NJ, US· patent location history
2019Based in Jiangsu, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 14 | 2013–2020 |
| LI GUOQINGself | 8 | 2012–2015 |
| HUANG YING | 6 | 2012–2014 |
| SCHERING CORP | 6 | 2009–2012 |
| ZHU ZHAONING | 6 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Belle Mead, New Jersey, US | 21 | 2009–2020 |
| Jiangsu, CN | 2 | 2019 |
| Kenilworth, New Jersey, US | 1 | 2013 |
| Staten Island, New York, US | 1 | 2003 |